Impact of breast reconstruction and different surgical approaches after neoadjuvant therapy on the long-term survival of breast cancer patients.

Transl Oncol · 2026 · PMC13011186 · PMID 41850052

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

For patients with different clinical stages, the surgical approach of NSM with BR showed a trend toward survival benefit (stage II: OS, HR: 0.59; 95 % CI: 0.34–1.02; BCSS, HR: 0.63; 95 % CI: 0.35–1.15; stage III: OS, HR: 0.54; 95 % CI: 0.29–1.02; BCSS: HR: 0.58; 95 % CI: 0.31–1.09).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.